Nathan J Schloemer

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Newly Diagnosed

Mesenchymal Stem Cells

Top Venues

Pediatric blood & cancer

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan J Schloemer, Wei Xue, Amira Qumseya, Leo Y Luo, Susan M Hiniker, Timothy B Lautz, Daniel S Rhee, Michael A Arnold, Rajkumar Venkatramani
Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatric blood & cancer (2024)
Nathan J Schloemer, Wei Xue, Amira Qumseya, Leo Y Luo, Susan M Hiniker, Timothy B Lautz, Daniel S Rhee, Michael A Arnold, Rajkumar Venkatramani
Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatric blood & cancer 71 (10) (2024)
Nathan J Schloemer, Wei Xue, Amira Qumseya, Leo Y Luo, Susan M Hiniker, Timothy B Lautz, Daniel S Rhee, Michael A Arnold, Rajkumar Venkatramani
Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatric blood & cancer (2024)
Nathan J Schloemer, Wei Xue, Amira Qumseya, Leo Y Luo, Susan M Hiniker, Timothy B Lautz, Daniel S Rhee, Michael A Arnold, Rajkumar Venkatramani
Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies. Pediatric blood & cancer (2023)
Mary Jo Rademacher, Anahi Cruz, Mary Faber, Robyn A A Oldham, Dandan Wang, Jeffrey A Medin, Nathan J Schloemer
Sarcoma IL-12 overexpression facilitates NK cell immunomodulation. Scientific reports 11 (1) (2021)